Top 10 Medical Equipment Stocks with Highest Upside: CBMX, OTIX, APT, WHRT, BLTI, DCTH, DSCI, VITA, WWIN, SLTM (Jul 12, 2010)
"Strong Buy" Rated U.S.-Listed Chinese Stocks (February 14, 2012)
Below are the top 10 Medical Equipment stocks with highest upside potential, based on the difference between current price and Wall Street analysts' average target price.
CombiMatrix Corporation (NASDAQ:CBMX) has the 1st highest upside potential in this segment of the market. Its upside is 517.3%. Its consensus target price is $15.00 based on the average of all estimates. Otix Global, Inc. (NASDAQ:OTIX) has the 2nd highest upside potential in this segment of the market. Its upside is 302.1%. Its consensus target price is $15.00 based on the average of all estimates. Alpha Pro Tech, Ltd. (AMEX:APT) has the 3rd highest upside potential in this segment of the market. Its upside is 223.3%. Its consensus target price is $5.63 based on the average of all estimates. WorldHeart Corporation (USA) (NASDAQ:WHRT) has the 4th highest upside potential in this segment of the market. Its upside is 193.0%. Its consensus target price is $7.50 based on the average of all estimates. Biolase Technology, Inc. (NASDAQ:BLTI) has the 5th highest upside potential in this segment of the market. Its upside is 185.7%. Its consensus target price is $4.00 based on the average of all estimates.
Delcath Systems, Inc. (NASDAQ:DCTH) has the 6th highest upside potential in this segment of the market. Its upside is 165.3%. Its consensus target price is $20.38 based on the average of all estimates. Derma Sciences, Inc. (NASDAQ:DSCI) has the 7th highest upside potential in this segment of the market. Its upside is 153.4%. Its consensus target price is $13.00 based on the average of all estimates. Orthovita, Inc. (NASDAQ:VITA) has the 8th highest upside potential in this segment of the market. Its upside is 129.1%. Its consensus target price is $4.86 based on the average of all estimates. Winner Medical Group, Inc (NASDAQ:WWIN) has the 9th highest upside potential in this segment of the market. Its upside is 121.1%. Its consensus target price is $10.50 based on the average of all estimates. Solta Medical Inc. (NASDAQ:SLTM) has the 10th highest upside potential in this segment of the market. Its upside is 102.8%. Its consensus target price is $3.57 based on the average of all estimates.